峆一药业
(430478)
| 流通市值：10.49亿 | | | 总市值：17.50亿 |
| 流通股本：4720.61万 | | | 总股本：7870.87万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 162,628,283 | 80,341,636.5 | 270,466,229.84 | 196,755,675.33 |
| 营业收入 | 162,628,283 | 80,341,636.5 | 270,466,229.84 | 196,755,675.33 |
| 二、营业总成本 | 118,774,479.66 | 60,975,738.28 | 219,747,298.5 | 159,583,009.37 |
| 营业成本 | 92,671,095.1 | 48,549,947.16 | 169,621,732.31 | 121,227,175.45 |
| 税金及附加 | 1,639,546.76 | 724,136.72 | 2,835,301.17 | 1,893,742.4 |
| 销售费用 | 1,439,083.37 | 903,567.34 | 2,008,623.53 | 1,331,995.81 |
| 管理费用 | 13,784,059.82 | 6,483,590.37 | 27,427,710.29 | 21,599,559.97 |
| 研发费用 | 10,144,258.44 | 4,785,242.61 | 20,513,979.77 | 15,384,389.34 |
| 财务费用 | -903,563.83 | -470,745.92 | -2,660,048.57 | -1,853,853.6 |
| 其中:利息费用 | 63,242.74 | - | 136,927.87 | 126,433.29 |
| 其中:利息收入 | 81,585.32 | - | 520,647.61 | 449,471.95 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -606,856 | -823,286.14 | 460,620.39 | 602,001.38 |
| 加:投资收益 | 1,796,012.44 | 1,426,611.02 | 3,324,305.74 | 2,692,577.69 |
| 资产处置收益 | - | -11,502.28 | - | - |
| 资产减值损失(新) | 161,456.34 | - | -2,963,536.99 | - |
| 信用减值损失(新) | 423,187.05 | 409,452.54 | -539,661.07 | 186,874.8 |
| 其他收益 | 1,463,409.1 | 1,074,607.38 | 2,815,761.15 | 1,456,879.77 |
| 四、营业利润 | 47,091,012.27 | 21,441,780.74 | 53,816,420.56 | 42,110,999.6 |
| 加:营业外收入 | 2,500.57 | 0.01 | 7,115.97 | 130,000 |
| 减:营业外支出 | 33,002.28 | 20,000 | 356,195.34 | 116,350.1 |
| 五、利润总额 | 47,060,510.56 | 21,421,780.75 | 53,467,341.19 | 42,124,649.5 |
| 减:所得税费用 | 8,605,212.18 | 3,334,352.62 | 8,834,128.22 | 6,289,312.13 |
| 六、净利润 | 38,455,298.38 | 18,087,428.13 | 44,633,212.97 | 35,835,337.37 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 38,455,298.38 | 18,087,428.13 | 44,633,212.97 | 35,835,337.37 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 40,425,452.53 | 19,231,299.51 | 49,664,051.16 | 37,401,751.95 |
| 少数股东损益 | -1,970,154.15 | -1,143,871.38 | -5,030,838.19 | -1,566,414.58 |
| 扣除非经常损益后的净利润 | 38,834,431.76 | 18,175,506.29 | 45,245,491.34 | 34,335,794.72 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.51 | 0.34 | 0.89 | 0.67 |
| (二)稀释每股收益 | - | - | 0.89 | - |
| 九、综合收益总额 | 38,455,298.38 | 18,087,428.13 | 44,633,212.97 | 35,835,337.37 |
| 归属于母公司股东的综合收益总额 | 40,425,452.53 | 19,231,299.51 | 49,664,051.16 | 37,401,751.95 |
| 归属于少数股东的综合收益总额 | -1,970,154.15 | -1,143,871.38 | -5,030,838.19 | -1,566,414.58 |
| 公告日期 | 2025-08-19 | 2025-04-28 | 2025-04-18 | 2024-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |